IP Library Granted Patent US 10,695,219
Granted Patent B2
US 10,695,219 · App. 15/482,480 · Granted Jun 30, 2020

Apparatus and method for treatment of dry eye using radio frequency heating

Inventors: Paul R. Herchman, Jr. (Grapevine, TX); Kevin D. O'Brien (Coppell, TX); Gregory L. Almond (Keller, TX)
Assignee: THERMIGEN, LLC
A61F9/0079A61N1/36014A61N1/36046
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,695,219
App. No.
15/482,480
Granted
Jun 30, 2020
Kind
B2
Abstract

The present disclosure is related to a treatment probe and method for treating dry eye. The treatment probe may include a thin stainless steel tip, a spacer to ensure proper contact and protect the skin of a patient, a sensor to provide temperature feedback to the power supply providing RF energy to the treatment probe. The treatment focuses on a patient's temple and periorbital area.

Claims (17)

1. A method of treatment for dry eye, the method comprising application of a radiofrequency energy to target tissue surrounding the eye in an amount sufficient to stimulate but not damage nerve tissue, wherein the radiofrequency energy is applied to the temple and then is applied to the periorbital tissue adjacent to the eye and/or eyelid.

2. A method according to claim 1 , wherein the radiofrequency energy is applied through a probe having at least one electrode surface that emits radiofrequency energy.

3. A method according to claim 1 , wherein the radiofrequency energy applied to is low frequency.

4. A method according to claim 1 , wherein the radiofrequency energy is emitted at a range of about 400 kHz to about 520 kHz; about 430 kHz to about 490 kHz; about 450 kHz to about 470 kHz; about 455 kHz to about 465 kHz; or about 460 kHz.

5. A method according to claim 1 , wherein the radiofrequency energy is applied in an amount necessary to stimulate nerves to induce secretion of one or more Meibomian glands.

6. A method according to claim 1 , wherein the radiofrequency energy is applied for a period of time and at a level necessary to raise the surface temperature of the target tissue to a temperature between 35 to 47 degrees Celsius.

7. A method according to claim 6 , wherein the radiofrequency energy is applied for a period of time and at a frequency necessary to raise the surface temperature of the target tissue to a temperature between 38 to 45 degrees Celsius.

8. A method according to claim 7 , wherein the radiofrequency energy is applied for a period of time and at a frequency necessary to raise the surface temperature of the target tissue to a temperature between 42 to 44 degrees Celsius.

9. A method according to claim 1 , wherein the target tissue is heated at between 1 and 5 mm beneath the surface of the target tissue.

10. A method according to claim 9 , wherein the method further comprises applying an electrically conductive gel at the site of the target tissue on a patient.

11. A method according to claim 1 , wherein the radiofrequency energy is applied for a period of 15 seconds to 20 minutes, a period of 8 minutes to 15 minutes; a period of 8 minutes to 10 minutes; a period of 10 minutes to 12 minutes; or a period of 12 to 15 minutes.

12. A method according to claim 1 , wherein the radiofrequency energy is not applied to the eyelid.

13. A method according to claim 1 , further comprising contacting a grounding pad to a patient on an area of the skin removed from the tissue surrounding the eye.

14. A method according to claim 1 , wherein the radiofrequency energy is applied using a probe that comprises:

a. an electrically conductive treatment tip positioned at the distal end of a handle,

b. a cable in contact with the treatment tip and running from the distal end of the handle to the proximal end of the handle, the cable extending from the handle to a power supply providing radio-frequency energy to the tip through the cord, wherein the cord is removable from the power supply

c. a spacer configured to provide an electrically conductive barrier between the treatment tip and a patient's skin, wherein the treatment tip is adapted to accept the spacer.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2020
From: ALMOND, GREGORY L.
To: THERMIGEN, LLC
Reel/Frame 052753/0680 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2018
From: HERCHMAN, PAUL R., JR.; O'BRIEN, KEVIN D.
To: THERMIGEN, LLC.
Reel/Frame 045431/0057 →
Continuity (2)
Provisional Application 62495592 · Apr 8, 2016
Related Publication 20170333249A1 · Nov 23, 2017
Cited By (1)
US 12,280,254